1 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 20 of 970 | 1720 prescriptions Less than 1% of all prescriptions | 1510 | 360 patients 16% of all patients | < 11 | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 170 of 1080 | 1020 prescriptions Less than 1% of all prescriptions | 710 | 240 patients 11% of all patients | < 11 | |
3 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 20 of 540 | 900 prescriptions Less than 1% of all prescriptions | 730 | 200 patients 9% of all patients | < 11 | |
4 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 140 of 820 | 860 prescriptions Less than 1% of all prescriptions | 860 | 220 patients 10% of all patients | 220 patients 10% of all patients | |
5 PREDNISONE | 110 of 1310 | 1490 prescriptions Less than 1% of all prescriptions | 1240 | 690 patients 31% of all patients | < 11 | |
6 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 260 of 1140 | 650 prescriptions Less than 1% of all prescriptions | | 180 patients 8% of all patients | < 11 | |
7 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 170 of 890 | 780 prescriptions Less than 1% of all prescriptions | 600 | 170 patients 8% of all patients | < 11 | |
8 VENTOLIN HFA (ALBUTEROL SULFATE) | 100 of 1220 | 1030 prescriptions Less than 1% of all prescriptions | 900 | 440 patients 20% of all patients | < 11 | |
9 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 50 of 300 | 640 prescriptions Less than 1% of all prescriptions | | 170 patients 8% of all patients | < 11 | |
10 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 40 of 260 | 340 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
11 FLOVENT HFA (FLUTICASONE PROPIONATE) | 90 of 350 | 300 prescriptions Less than 1% of all prescriptions | 300 | < 11 | < 11 | |
12 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 160 of 730 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 FUROSEMIDE | 120 of 440 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
14 PROAIR HFA (ALBUTEROL SULFATE) | 230 of 950 | 440 prescriptions Less than 1% of all prescriptions | | 180 patients 8% of all patients | < 11 | |
15 LETAIRIS (AMBRISENTAN) | 80 of 130 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 AZITHROMYCIN | 430 of 970 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
17 SPIRIVA (TIOTROPIUM BROMIDE) | 550 of 1100 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 UPTRAVI (SELEXIPAG) | 30 of 30 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
19 ADEMPAS (RIOCIGUAT) | 40 of 80 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
20 OFEV (NINTEDANIB ESYLATE) | 150 of 230 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
21 TRIAZOLAM | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
22 OPSUMIT (MACITENTAN) | 50 of 60 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
23 FLUCONAZOLE | 30 of 50 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
24 LEVOFLOXACIN | 150 of 210 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |